Uploaded image for project: 'eCQM Issue Tracker'
  1. eCQM Issue Tracker
  2. CQM-5641

Safe Use of Opioids-Concurrent Prescribing

XMLWordPrintable

    • Icon: EH/CAH eCQMs EH/CAH eCQMs
    • Resolution: Answered
    • Icon: Moderate Moderate
    • None
    • None
    • Cynthia Indelicato
    • 631 444-4491
    • Stony Brook Medicine
    • Hide
      ​​Thank you for your question. For Safe Use of Opioids - Concurrent Prescribing - CMS506v5 published in May 2022, we removed all buprenorphine/naloxone combination medications, such as suboxone, from the Schedule II & III Opioid Medications value set (2.16.840.1.113762.1.4.1111.16), which is used to identify both the denominator and numerator patients. Our intent is to avoid disincentivizing evidence-based treatment of opioid use disorder. Given this vale set update, patients receiving only suboxone should not be in the measure.
      Please let us know if you have additional questions.

      Show
      ​​Thank you for your question. For Safe Use of Opioids - Concurrent Prescribing - CMS506v5 published in May 2022, we removed all buprenorphine/naloxone combination medications, such as suboxone, from the Schedule II & III Opioid Medications value set (2.16.840.1.113762.1.4.1111.16), which is used to identify both the denominator and numerator patients. Our intent is to avoid disincentivizing evidence-based treatment of opioid use disorder. Given this vale set update, patients receiving only suboxone should not be in the measure. Please let us know if you have additional questions.
    • CMS0506v4
    • Patients falling into the numerator (non-compliant)

      Suboxone strengths are not available in 10mg, which are frequently prescribed at discharge. Therefore physicians have to order a 2mg AND 8mg tablet causing patients to fall into the numerator. Why. if this is an acceptable treatment for patients with an opioid dependence? Or can this be a considered update for Opioid-Concurrent Prescribing specifications in the future?

            JLeflore Mathematica EH eCQM Team
            cindelic Cynthia Indelicato
            Votes:
            0 Vote for this issue
            Watchers:
            2 Start watching this issue

              Created:
              Updated:
              Resolved:
              Solution Posted On: